
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 811-820
Open Access | Times Cited: 56
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 811-820
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Pathophysiology of Post-COVID syndromes: a new perspective
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 96
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 96
Hyperinflammatory Response in COVID-19: A Systematic Review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Maria Isabel Montoril Gouveia, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 553-553
Open Access | Times Cited: 73
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Maria Isabel Montoril Gouveia, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 553-553
Open Access | Times Cited: 73
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Hani Faidah, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2017-2026
Open Access | Times Cited: 58
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Hani Faidah, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2017-2026
Open Access | Times Cited: 58
The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 45
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diagnostics (2022) Vol. 12, Iss. 9, pp. 2051-2051
Open Access | Times Cited: 45
Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 40
Asma W. Al-Thomali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2032-2032
Open Access | Times Cited: 40
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
Janis K. Shute
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 584-584
Open Access | Times Cited: 26
Janis K. Shute
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 584-584
Open Access | Times Cited: 26
Coagulation Disorders in Sepsis and COVID-19—Two Sides of the Same Coin? A Review of Inflammation–Coagulation Crosstalk in Bacterial Sepsis and COVID-19
Georgeana Tuculeanu, Ecaterina Constanța Barbu, Mihai Lazăr, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 601-601
Open Access | Times Cited: 23
Georgeana Tuculeanu, Ecaterina Constanța Barbu, Mihai Lazăr, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 2, pp. 601-601
Open Access | Times Cited: 23
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19
Hayder M. Al‐kuraishy, Nawar Raad Hussien, Marwa S. Al‐Niemi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Hayder M. Al‐kuraishy, Nawar Raad Hussien, Marwa S. Al‐Niemi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Long COVID (PASC) Is Maintained by a Self-Sustaining Pro-Inflammatory TLR4/RAGE-Loop of S100A8/A9 > TLR4/RAGE Signalling, Inducing Chronic Expression of IL-1b, IL-6 and TNFa: Anti-Inflammatory Ezrin Peptides as Potential Therapy
Rupert Holms
Immuno (2022) Vol. 2, Iss. 3, pp. 512-533
Open Access | Times Cited: 26
Rupert Holms
Immuno (2022) Vol. 2, Iss. 3, pp. 512-533
Open Access | Times Cited: 26
Comparison of Vitamin D and Resveratrol Performances in COVID-19
Cristina Russo, Maria Stella Valle, Luisa Malaguarnera, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2639-2639
Open Access | Times Cited: 15
Cristina Russo, Maria Stella Valle, Luisa Malaguarnera, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2639-2639
Open Access | Times Cited: 15
Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2271-2279
Open Access | Times Cited: 14
The Important Role of Interleukin-2 in COVID-19
Leila Ghanbari Naeini, Laleh Abbasi, Farzaneh Karimi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 14
Leila Ghanbari Naeini, Laleh Abbasi, Farzaneh Karimi, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 14
Cytokine Levels and Severity of Illness Scoring Systems to Predict Mortality in COVID-19 Infection
Sevda Onuk, Hilal Sipahioğlu, Samet Karahan, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 387-387
Open Access | Times Cited: 13
Sevda Onuk, Hilal Sipahioğlu, Samet Karahan, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 387-387
Open Access | Times Cited: 13
Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sumaiah J. Alarfaj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sumaiah J. Alarfaj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sadiq M. Al‐Hamash, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sadiq M. Al‐Hamash, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Sesquiterpene nootkatone counteracted the melamine-induced neurotoxicity via repressing of oxidative stress, inflammatory, and apoptotic trajectories
Ola A. Habotta, Ahmed Abdeen, Aya A. El-Hanafy, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115133-115133
Open Access | Times Cited: 12
Ola A. Habotta, Ahmed Abdeen, Aya A. El-Hanafy, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115133-115133
Open Access | Times Cited: 12
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 11
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 11
Sulfasalazine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and nuclear factor-kappaB pathways
Haipeng Cheng, Xingwen Bao, Yong-yu Luo, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 169, pp. 106530-106530
Open Access | Times Cited: 4
Haipeng Cheng, Xingwen Bao, Yong-yu Luo, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 169, pp. 106530-106530
Open Access | Times Cited: 4
Moringa oleifera leaf polysaccharide alleviates experimental colitis by inhibiting inflammation and maintaining intestinal barrier
Hosameldeen Mohamed Husien, Weilong Peng, SU Hong-rui, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
Hosameldeen Mohamed Husien, Weilong Peng, SU Hong-rui, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 9
Serum HMGB1 and Soluble Urokinase Plasminogen Activator Receptor Levels Aid Diagnosis and Prognosis Prediction of Sepsis with Acute Respiratory Distress Syndrome
Yuanhua Fan, Zhimei Ye, Yan Tang
Biomarkers in Medicine (2023) Vol. 17, Iss. 4, pp. 231-239
Closed Access | Times Cited: 9
Yuanhua Fan, Zhimei Ye, Yan Tang
Biomarkers in Medicine (2023) Vol. 17, Iss. 4, pp. 231-239
Closed Access | Times Cited: 9
Citicoline and COVID-19: vis-à-vis conjectured
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 9
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 9